Michael B. Hoffman

All filings by Michael B. Hoffman on record concern Annovis Bio, Inc., in the capacity of board member. Between 4 January 2022 and 20 May 2026, the trades on record add up to 21 filings.

Purchases make up the whole of the open-market record (13 purchases, €3.5M). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 7 share grants and 1 option exercise. Since January 2026: 4 purchases and no sales on the market.

Half of the purchases are above €30k and half below. Scaled by market value, the purchases weigh a median 0.046% of market cap (sample: 3 purchases). Of 12 purchases, 7 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

On 21 May 2026 came the latest disclosure, an open-market purchase for €29k in Annovis Bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.